Men, *Xiaoyu, Taylor, Z. L., Marshe, V. S., Blumberger, D. M., Karp, J. F., Kennedy, J. L., Lenze, E. J., Iii, C. F. R., Stefan, C., Mulsant, B. H., Ramsey, L. B., & Müller, D. J. (2025). UNDERSTANDING THE IMPACT OF CYP2D6-MEDIATED VENLAFAXINE PHARMACOKINETICS ON TREATMENT OUTCOMES IN LATE-LIFE DEPRESSION. International Journal of Neuropsychopharmacology, 28(Supplement_1), i329–i330. https://doi.org/10.1093/ijnp/pyae059.589

Bulthuis, N. E., McGowan, J. C., Ladner, L. R., LaGamma, C. T., Lim, S. C., Shubeck, C. X., Brachman, R. A., Sydnor, E., Pavlova, I. P., Seo, D., Drew, M. R., & Denny, C. A. (2024). GluN2B on Adult-Born Granule Cells Modulates (R,S)-Ketamine’s Rapid-Acting Effects in Mice. International Journal of Neuropsychopharmacology, 27(10). https://doi.org/10.1093/ijnp/pyae036

Gärde, M., Matheson, G. J., Varnäs, K., Svenningsson, P., Hedman-Lagerlöf, E., Lundberg, J., Farde, L., & Tiger, M. (2024). Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect. International Journal of Neuropsychopharmacology, 27(5). https://doi.org/10.1093/ijnp/pyae021

Sajid, S., Galfalvy, H. C., Keilp, J. G., Burke, A. K., Mann, J. J., & Grunebaum, M. F. (2024). Acute Dissociation and Ketamine’s Antidepressant and Anti-Suicidal Ideation Effects in a Midazolam-Controlled Trial. International Journal of Neuropsychopharmacology, 27(4). https://doi.org/10.1093/ijnp/pyae017

Kogan, C. S., Garcia-Pacheco, J. A., Rebello, T. J., Montoya, M. I., Robles, R., Khoury, B., Kulygina, M., Matsumoto, C., Huang, J., Medina-Mora, M. E., Gureje, O., Stein, D. J., Sharan, P., Gaebel, W., Kanba, S., Andrews, H. F., Roberts, M. C., Pike, K. M., Zhao, M., … Reed, G. M. (2023). Longitudinal Impact of the COVID-19 Pandemic on Stress and Occupational Well-Being of Mental Health Professionals: An International Study. International Journal of Neuropsychopharmacology, 26(10), 747–760. https://doi.org/10.1093/ijnp/pyad046

Underwood, M. D., Galfalvy, H., Hsiung, S., Liu, Y., Simpson, N. R., Bakalian, M. J., Rosoklija, G. B., Dwork, A. J., Arango, V., & Mann, J. J. (2023). A Stress Protein–Based Suicide Prediction Score and Relationship to Reported Early-Life Adversity and Recent Life Stress. International Journal of Neuropsychopharmacology, 26(7), 501–512. https://doi.org/10.1093/ijnp/pyad025

Iturra-Mena, A. M., Kangas, B. D., & Pizzagalli, D. A. (2023). Nociceptin Receptor Antagonism Modulates Electrophysiological Markers of Reward Learning. International Journal of Neuropsychopharmacology, 26(7), 496–500. https://doi.org/10.1093/ijnp/pyad031

Kantrowitz, J. T., Correll, C. U., Jain, R., & Cutler, A. J. (2023). New Developments in the Treatment of Schizophrenia: An Expert Roundtable. International Journal of Neuropsychopharmacology, 26(5), 322–330. https://doi.org/10.1093/ijnp/pyad011

Deckler, E., Ferland, M., Brazis, S., Mayer, M. R., Carlson, M., & Kantrowitz, J. T. (2022). Challenges and Strategies for the Recruitment of Patients With Schizophrenia in a Research Setting. International Journal of Neuropsychopharmacology, 25(11), 924–932. https://doi.org/10.1093/ijnp/pyac058

Bloomfield-Clagett, B., Ballard, E. D., Greenstein, D. K., Wilkinson, S. T., Grunebaum, M. F., Murrough, J. W., Mathew, S. J., Phillips, J. L., Fava, M., Sanacora, G., & Zarate, C. A. (2022). A Participant-Level Integrative Data Analysis of Differential Placebo Response for Suicidal Ideation and Nonsuicidal Depressive Symptoms in Clinical Trials of Intravenous Racemic Ketamine. International Journal of Neuropsychopharmacology, 25(10), 827–838. https://doi.org/10.1093/ijnp/pyac055

Raghuraman, R., Manakkadan, A., Richter-Levin, G., & Sajikumar, S. (2022). Inhibitory Metaplasticity in Juvenile Stressed Rats Restores Associative Memory in Adulthood by Regulating Epigenetic Complex G9a/GLP. International Journal of Neuropsychopharmacology, 25(7), 576–589. https://doi.org/10.1093/ijnp/pyac008

Lan, M. J., Zanderigo, F., Pantazatos, S. P., Sublette, M. E., Miller, J., Ogden, R. T., & Mann, J. J. (2022). Serotonin 1A Receptor Binding of [11C]CUMI-101 in Bipolar Depression Quantified Using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response. International Journal of Neuropsychopharmacology, 25(7), 534–544. https://doi.org/10.1093/ijnp/pyac001

Mastrodonato, A., Pavlova, I., Kee, N. C., Pham, V. A., McGowan, J. C., Mann, J. J., & Denny, C. A. (2022). Prophylactic (R,S)-Ketamine Is Effective Against Stress-Induced Behaviors in Adolescent but Not Aged Mice. International Journal of Neuropsychopharmacology, 25(6), 512–523. https://doi.org/10.1093/ijnp/pyac020

Melhem, N. M., Zhong, Y., Miller, J. M., Zanderigo, F., Ogden, R. T., Sublette, M. E., Newell, M., Burke, A., Keilp, J. G., Lesanpezeshki, M., Bartlett, E., Brent, D. A., & Mann, J. J. (2021). Brain 5-HT1A Receptor PET Binding, Cortisol Responses to Stress, and the Familial Transmission of Suicidal Behavior. International Journal of Neuropsychopharmacology, 25(1), 36–45. https://doi.org/10.1093/ijnp/pyab060